| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.7M | -61.3% |
| Cost of Revenue | $619K | -81.5% |
| R&D Expense | $166.6M | -19.5% |
| SG&A Expense | $52.2M | -11.5% |
| Operating Income | -$168.2M | -38.6% |
| Interest Expense | $1.4M | — |
| Income Tax | $0 | — |
| Net Income | -$9.1M | +92.4% |
| EPS (Basic) | -$0.15 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.0M | -7.3% |
| Accounts Receivable | $10.4M | -81.6% |
| Inventory | $1.2M | -15.9% |
| Current Assets | $251.3M | +13.1% |
| Total Assets | $298.4M | +6.4% |
| Current Liabilities | $56.1M | +15.4% |
| Total Liabilities | $145.8M | +5.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.2M | +10.1% |
| Capital Expenditures | $1.8M | -51.3% |
| Investing Cash Flow | -$80.1M | -213.2% |
| Financing Cash Flow | $150.4M | +8963.4% |
| Free Cash Flow | -$80.0M | +11.7% |
| +92.3% |
| EPS (Diluted) | -$0.15 | +92.3% |
| Stockholders' Equity |
| $152.6M |
| +7.5% |